Sophocarpine Alleviates Renal Ischemia–Reperfusion Injury by Mitigating Oxidative Stress and Mitochondrial Dysfunction via the SIRT1/PGC-1α Axis
Open Access
- 16 June 2026
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 14 (6) , 1357
Abstract
Background/Objectives: Renal ischemia–reperfusion injury (IRI) is a major cause of acute kidney injury and delayed graft function after kidney transplantation. Oxidative stress, mitochondrial dysfunction, and tubular epithelial cell apoptosis are central events in renal IRI. Sophocarpine (SOP), a quinolizidine alkaloid derived from Sophora species, has reported antioxidant and anti-apoptotic activities, but its effects in renal IRI remain unclear. This study investigated the role and function of SOP in renal IRI. Methods: A bilateral renal IRI mouse model and a hypoxia/reoxygenation (H/R) model in HK-2 human proximal tubular epithelial cells were used. Renal function, histological injury, apoptosis, reactive oxygen species, malondialdehyde, superoxide dismutase activity, glutathione, mitochondrial morphology, mitochondrial membrane potential, and mitochondrial dynamics-related proteins were evaluated. SIRT1 dependency was examined using Sirt1 small interfering RNA in HK-2 cells and EX527-mediated SIRT1 inhibition in mice. Results: SOP pretreatment reduced serum creatinine and blood urea nitrogen levels, attenuated tubular injury and apoptosis, decreased oxidative stress, and preserved mitochondrial morphology and function after renal IRI. Similar protective effects were observed in HK-2 cells exposed to H/R. SOP increased SIRT1 and PGC-1α expression, whereas Sirt1 knockdown or pharmacological SIRT1 inhibition weakened the antioxidant and mitochondrial protective effects of SOP. Conclusions: SOP attenuates renal IRI-associated oxidative stress and mitochondrial dysfunction, at least in part through the SIRT1/PGC-1α axis. These findings support further investigation of SOP as a candidate renoprotective compound for ischemic kidney injury.Keywords
Funding Information
- National Natural Science Foundation of China (82170664)
This publication has 33 references indexed in Scilit:
- Tubule-derived growth differentiation factor 15 limits renal transplant injury by reprogramming macrophage responsesAmerican Journal of Transplantation, 2026
- Dahuang Gancao decoction suppresses ferroptosis via SIRT3-mediated NRF2 deacetylation in acute kidney injuryPhytomedicine, 2025
- Ischemia - Reperfusion injury: A roadmap to precision therapiesMolecular Aspects of Medicine, 2025
- Schisandrin B regulates mitochondrial dynamics via AKT1 activation and mitochondrial targeting to ameliorate renal ischemia-reperfusion injuryPhytomedicine, 2025
- Investigation of the anti-inflammatory, anti-pruritic, and analgesic effects of sophocarpine inhibiting TRP channels in a mouse model of inflammatory itch and painJournal of Ethnopharmacology, 2024
- Unlocking renal Restoration: Mesaconine from Aconitum plants restore mitochondrial function to halt cell apoptosis in acute kidney injuryInternational Immunopharmacology, 2024
- MiR-132-3p activation aggravates renal ischemia-reperfusion injury by targeting Sirt1/PGC1alpha axisCellular Signalling, 2023
- The roles of PKC-δ and PKC-ε in myocardial ischemia/reperfusion injuryPharmacological Research, 2021
- Sophocarpine attenuates murine lupus nephritis via inhibiting NLRP3 inflammasome and NF-κB activationImmunologic Research, 2018
- The risk of allograft failure and the survival benefit of kidney transplantation are complicated by delayed graft functionKidney International, 2016